Dave Ramsey Advises Single Mother on IRS Tax Debt Relief Program After 8000 Surprise AI Wealth Must Benefit Public South Korea Deputy PM Warns Amid Samsung Labor Dispute Flex Ltd Expands Collaboration with Teradyne Robotics to Advance Intelligent Automation in Manufacturing New Freight Pricing Model Raises Costs for Gorey Businesses Local Concerns Mount Alphabet and Sandisk Identified as Potential AI Value Plays Through 2028 TSX Retreats from Record High as Technology Stocks Decline First Watch Restaurant Group Inc FWRG Q1 2026 Earnings EPS Miss Slightly Weighs on Sentiment COHR Q1 2026 Earnings EPS Misses Estimates Stock Sees Marginal Decline PTCT Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline Amid Pipeline Progress Rexford Industrial Realty Inc REXR Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction GPOR Q1 2026 Earnings EPS Slightly Misses Consensus Shares Edge Lower STKS Q1 2026 Earnings Widening Losses as EPS Misses Estimates by 146 Jiuzi Holdings JZXN Edges Higher as Stock Tests Key Resistance Levels American Financial Group Subordinated Debentures AFGC Steady Near 1845 as LowVolume Trading Persists Alico Inc Holds Steady Near 4085 as Market Consolidates Passage Bio PASG Holds Steady Near Support as Gene Therapy Sector Faces Crosscurrents Vertiv Holdings VRT Reaches 32746 After Modest Gain Nears Key Resistance Level Luhansk Strike Escalates Geopolitical Tensions Market Uncertainty May Follow RMCO Q4 2025 Earnings Significant EPS Miss Despite Stock Rally Thayer Ventures Acquisition TVAI Holds Steady at 1029 as SPAC Market Watches for Catalyst RY Q1 2026 Earnings EPS Beats Estimates by 30 Amid Resilient Banking Operations OMF Q1 2026 Earnings EPS Beat Drives Modest Share Price Uptick ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Deutsche Bank Q1 2026 Earnings Modest EPS Beat Amid Mixed Market Sentiment GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues ICON plc Q3 2025 Earnings EPS Misses Estimates Amid Cautious Demand Signals INMB Q4 2025 Earnings Narrowing Losses Amid Clinical Pipeline Progress